Abstract

PurposeTo review and synthesise prognostic indices that predict subsequent risk, prescriptive indices that moderate treatment response, and mechanisms that underlie each with respect to relapse and recurrence of depression in adults. Results and conclusionsChildhood maltreatment, post-treatment residual symptoms, and a history of recurrence emerged as strong prognostic indicators of risk and each could be used prescriptively to indicate who benefits most from continued or prophylactic treatment. Targeting prognostic indices or their “down-stream” consequences will be particularly beneficial because each is either a cause or a consequence of the causal mechanisms underlying risk of recurrence. The cognitive and neural mechanisms that underlie the prognostic indices are likely addressed by the effects of treatments that are moderated by the prescriptive factors. For example, psychosocial interventions that target the consequences of childhood maltreatment, extending pharmacotherapy or adapting psychological therapies to deal with residual symptoms, or using cognitive or mindfulness-based therapies for those with prior histories of recurrence. Future research that focuses on understanding causal pathways that link childhood maltreatment, or cognitive diatheses, to dysfunction in the neocortical and limbic pathways that process affective information and facilitate cognitive control, might result in more enduring effects of treatments for depression.

Highlights

  • Depression has the highest disease burden worldwide in terms of life-years lost to disability (Prince et al, 2007)

  • Study 1 was a meta-review of systematic reviews and found that two prognostic factors were consistently associated with relapse or recurrence, with strong evidence: childhood maltreatment and residual symptoms of depression post-treatment

  • There was some suggestion that both factors may act as prescriptive factors that moderate treatment effects, childhood maltreatment was only assessed in one primary study reported in a single review (Clarke et al, 2015) and residual symptoms was only assessed in a handful of primary studies in two reviews (Beshai et al, 2011; Feng et al, 2012)

Read more

Summary

Introduction

Depression has the highest disease burden worldwide in terms of life-years lost to disability (Prince et al, 2007). It is highly prevalent, results in significant functional impairment, and increases the risk of suicide and comorbid physical health problems (Judd, 1997; Kessler & Wang, 2009). While depression traditionally has been seen as an episodic disorder with good inter-morbid functioning (Angst, Kupfer, & Rosenbaum, 1996), it is thought by many to follow a “relapsing-remitting” course with debilitating subsyndromal symptoms occurring between discrete episodes

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call